161 related articles for article (PubMed ID: 30277395)
21. Different tau epitopes define Abeta42-mediated tau insolubility.
Pennanen L; Götz J
Biochem Biophys Res Commun; 2005 Dec; 337(4):1097-101. PubMed ID: 16226718
[TBL] [Abstract][Full Text] [Related]
22. Tumor-suppressor PTEN affects tau phosphorylation, aggregation, and binding to microtubules.
Zhang X; Li F; Bulloj A; Zhang YW; Tong G; Zhang Z; Liao FF; Xu H
FASEB J; 2006 Jun; 20(8):1272-4. PubMed ID: 16645045
[TBL] [Abstract][Full Text] [Related]
23. Pseudo-phosphorylation at AT8 epitopes regulates the tau truncation at aspartate 421.
Cao L; Liang Y; Liu Y; Xu Y; Wan W; Zhu C
Exp Cell Res; 2018 Sep; 370(1):103-115. PubMed ID: 29908160
[TBL] [Abstract][Full Text] [Related]
24. The pattern of human tau phosphorylation is the result of priming and feedback events in primary hippocampal neurons.
Bertrand J; Plouffe V; Sénéchal P; Leclerc N
Neuroscience; 2010 Jun; 168(2):323-34. PubMed ID: 20394726
[TBL] [Abstract][Full Text] [Related]
25. Okadaic acid-induced tau hyperphosphorylation and the downregulation of Pin1 expression in primary cortical neurons.
Metin-Armağan D; Gezen-Ak D; Dursun E; Atasoy İL; Karabay A; Yılmazer S; Öztürk M
J Chem Neuroanat; 2018 Oct; 92():41-47. PubMed ID: 29860071
[TBL] [Abstract][Full Text] [Related]
26. Selection of aptamers targeting the sialic acid receptor of hemagglutinin by epitope-specific SELEX.
Lao YH; Chiang HY; Yang DK; Peck K; Chen LC
Chem Commun (Camb); 2014 Aug; 50(63):8719-22. PubMed ID: 24964092
[TBL] [Abstract][Full Text] [Related]
27. Novel Lipidized Analog of Prolactin-Releasing Peptide Improves Memory Impairment and Attenuates Hyperphosphorylation of Tau Protein in a Mouse Model of Tauopathy.
Popelová A; Pražienková V; Neprašová B; Kasperová BJ; Hrubá L; Holubová M; Zemenová J; Blum D; Železná B; Galas MC; Kuneš J; Maletínská L
J Alzheimers Dis; 2018; 62(4):1725-1736. PubMed ID: 29614684
[TBL] [Abstract][Full Text] [Related]
28. Comparative distribution of tau phosphorylated at Ser262 in pre-tangles and tangles.
Lauckner J; Frey P; Geula C
Neurobiol Aging; 2003 Oct; 24(6):767-76. PubMed ID: 12927759
[TBL] [Abstract][Full Text] [Related]
29. Increased tau phosphorylation at the Ser396 epitope after amyloid beta-exposure in organotypic cultures.
Johansson S; Jämsä A; Vasänge M; Winblad B; Luthman J; Cowburn RF
Neuroreport; 2006 Jun; 17(9):907-11. PubMed ID: 16738486
[TBL] [Abstract][Full Text] [Related]
30. Generation and characterization of novel DNA aptamers against coat protein of grouper nervous necrosis virus (GNNV) with antiviral activities and delivery potential in grouper cells.
Zhou L; Li P; Yang M; Yu Y; Huang Y; Wei J; Wei S; Qin Q
Antiviral Res; 2016 May; 129():104-114. PubMed ID: 26892075
[TBL] [Abstract][Full Text] [Related]
31. Modulation of tau phosphorylation and intracellular localization by cellular stress.
Jenkins SM; Zinnerman M; Garner C; Johnson GV
Biochem J; 2000 Jan; 345 Pt 2(Pt 2):263-70. PubMed ID: 10620503
[TBL] [Abstract][Full Text] [Related]
32. Earliest stages of tau conformational changes are related to the appearance of a sequence of specific phospho-dependent tau epitopes in Alzheimer's disease.
Luna-Muñoz J; Chávez-Macías L; García-Sierra F; Mena R
J Alzheimers Dis; 2007 Dec; 12(4):365-75. PubMed ID: 18198423
[TBL] [Abstract][Full Text] [Related]
33. GSK-3 dependent phosphoepitopes recognized by PHF-1 and AT-8 antibodies are present in different tau isoforms.
Hernández F; Lucas JJ; Cuadros R; Avila J
Neurobiol Aging; 2003 Dec; 24(8):1087-94. PubMed ID: 14643380
[TBL] [Abstract][Full Text] [Related]
34. Current Understanding of Neurodegenerative Diseases Associated With the Protein Tau.
Josephs KA
Mayo Clin Proc; 2017 Aug; 92(8):1291-1303. PubMed ID: 28778262
[TBL] [Abstract][Full Text] [Related]
35. Hyperphosphorylation of tau in PHF.
Morishima-Kawashima M; Hasegawa M; Takio K; Suzuki M; Yoshida H; Watanabe A; Titani K; Ihara Y
Neurobiol Aging; 1995; 16(3):365-71; discussion 371-80. PubMed ID: 7566346
[TBL] [Abstract][Full Text] [Related]
36. Alzheimer-specific epitope of AT100 in transfected cell lines with tau: toward an efficient cell model of tau abnormal phosphorylation.
Mailliot C; Bussière T; Caillet-Boudin ML; Delacourte A; Buée L
Neurosci Lett; 1998 Oct; 255(1):13-6. PubMed ID: 9839715
[TBL] [Abstract][Full Text] [Related]
37. Temsirolimus attenuates tauopathy in vitro and in vivo by targeting tau hyperphosphorylation and autophagic clearance.
Jiang T; Yu JT; Zhu XC; Zhang QQ; Cao L; Wang HF; Tan MS; Gao Q; Qin H; Zhang YD; Tan L
Neuropharmacology; 2014 Oct; 85():121-30. PubMed ID: 24880087
[TBL] [Abstract][Full Text] [Related]
38. Effects of cyclin-dependent kinase-5 activity on apoptosis and tau phosphorylation in immortalized mouse brain cortical cells.
Shelton SB; Krishnamurthy P; Johnson GV
J Neurosci Res; 2004 Apr; 76(1):110-20. PubMed ID: 15048935
[TBL] [Abstract][Full Text] [Related]
39. Melatonin ameliorates amyloid beta-induced memory deficits, tau hyperphosphorylation and neurodegeneration via PI3/Akt/GSk3β pathway in the mouse hippocampus.
Ali T; Kim MO
J Pineal Res; 2015 Aug; 59(1):47-59. PubMed ID: 25858697
[TBL] [Abstract][Full Text] [Related]
40. Absence of abnormal hyperphosphorylation of tau in intracellular tangles in Alzheimer's disease.
Bondareff W; Harrington CR; Wischik CM; Hauser DL; Roth M
J Neuropathol Exp Neurol; 1995 Sep; 54(5):657-63. PubMed ID: 7666054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
